HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$1.37
Day range
$1.32 - $2.11
Year range
$1.11 - $5.74
Market cap
15.98M USD
Avg Volume
916.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.20M | -28.72% |
Net income | -4.07M | 30.65% |
Net profit margin | — | — |
Earnings per share | -0.36 | 33.33% |
EBITDA | -4.20M | 28.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.12M | -57.86% |
Total assets | 11.04M | -56.84% |
Total liabilities | 4.50M | 2.68% |
Total equity | 6.53M | — |
Shares outstanding | 11.25M | — |
Price to book | 2.36 | — |
Return on assets | -85.20% | — |
Return on capital | -128.97% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.07M | 30.65% |
Cash from operations | -2.79M | 29.70% |
Cash from investing | -1.70M | -149.43% |
Cash from financing | 526.46K | — |
Net change in cash | -3.97M | -570.34% |
Free cash flow | -2.46M | -24.30% |
About
Founded
2013
Headquarters
Website
Employees
24
